Chengdu Guibao Science & TechnologyLtd（300019）株式概要成都桂博科技有限公司 詳細300019 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長1/6過去の実績2/6財務の健全性6/6配当金4/6報酬株価収益率（ 23.5 x） CN市場（ 42.5 x）を下回っています。収益は年間14.46%増加すると予測されています リスク分析不安定な配当実績 すべてのリスクチェックを見る300019 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW476,491 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA476,491 investors already sharing narrativesYour Fair ValueCN¥Current PriceCN¥15.1629.0% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture07b2016201920222025202620282031Revenue CN¥7.4bEarnings CN¥490.0mAdvancedSet Fair ValueView all narrativesChengdu Guibao Science & Technology Co.,Ltd. 競合他社ZETTA GroupSymbol: SZSE:002256Market cap: CN¥7.3bLiaoning Xinde New Material TechnologySymbol: SZSE:301349Market cap: CN¥6.4bXi'an Manareco New MaterialsLtdSymbol: SHSE:688550Market cap: CN¥7.0bPan Asian Microvent Tech (Jiangsu)Symbol: SHSE:688386Market cap: CN¥5.4b価格と性能株価の高値、安値、推移の概要Chengdu Guibao Science & TechnologyLtd過去の株価現在の株価CN¥15.1652週高値CN¥26.6552週安値CN¥13.30ベータ0.591ヶ月の変化6.91%3ヶ月変化-12.97%1年変化-29.06%3年間の変化-6.01%5年間の変化-36.38%IPOからの変化114.28%最新ニュースBuy Or Sell Opportunity • Jul 21Now 24% overvaluedOver the last 90 days, the stock has fallen 25% to CN¥14.09. The fair value is estimated to be CN¥11.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 42% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥16.12, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 19x in the Chemicals industry in China. Negligible returns to shareholders over past three years.お知らせ • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026Declared Dividend • Apr 27Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2026 Payment date: 30th April 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (47% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 50% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 21, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 21, 2026Reported Earnings • Mar 30Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.71 (up from CN¥0.61 in FY 2024). Revenue: CN¥3.75b (up 19% from FY 2024). Net income: CN¥278.5m (up 17% from FY 2024). Profit margin: 7.4% (down from 7.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.最新情報をもっと見るRecent updatesBuy Or Sell Opportunity • Jul 21Now 24% overvaluedOver the last 90 days, the stock has fallen 25% to CN¥14.09. The fair value is estimated to be CN¥11.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 42% in the next 2 years.Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥16.12, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 19x in the Chemicals industry in China. Negligible returns to shareholders over past three years.お知らせ • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026Declared Dividend • Apr 27Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2026 Payment date: 30th April 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (47% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 50% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 21, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 21, 2026Reported Earnings • Mar 30Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.71 (up from CN¥0.61 in FY 2024). Revenue: CN¥3.75b (up 19% from FY 2024). Net income: CN¥278.5m (up 17% from FY 2024). Profit margin: 7.4% (down from 7.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.お知らせ • Mar 28Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026, at 14:00 China Standard Time. Location: No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan ChinaValuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥18.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 17% over the past three years.Reported Earnings • Feb 10Full year 2025 earnings released: EPS: CN¥0.71 (vs CN¥0.61 in FY 2024)Full year 2025 results: EPS: CN¥0.71 (up from CN¥0.61 in FY 2024). Revenue: CN¥3.75b (up 19% from FY 2024). Net income: CN¥281.1m (up 18% from FY 2024). Profit margin: 7.5% (in line with FY 2024). Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.お知らせ • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 28, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 28, 2026Valuation Update With 7 Day Price Move • Nov 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥21.09, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 28% over the past three years.Reported Earnings • Oct 22Third quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.14 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.14 in 3Q 2024). Revenue: CN¥943.8m (down 3.1% from 3Q 2024). Net income: CN¥74.9m (up 32% from 3Q 2024). Profit margin: 7.9% (up from 5.8% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Aug 26Second quarter 2025 earnings released: EPS: CN¥0.21 (vs CN¥0.16 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.21 (up from CN¥0.16 in 2Q 2024). Revenue: CN¥928.7m (up 36% from 2Q 2024). Net income: CN¥83.2m (up 35% from 2Q 2024). Profit margin: 9.0% (in line with 2Q 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Jul 10Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥24.32, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 18% over the past three years.New Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (7.7% net profit margin).お知らせ • Jul 02Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥20.10, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 5.1% over the past three years.お知らせ • May 09Chengdu Guibao Science & Technology Co.,Ltd. Announces Director AppointmentsChengdu Guibao Science & Technology Co.,Ltd. at its EGM held on May 7, 2025, approved: Election and nomination of non-independent and independent directors: Zhao Kexing, non-independent director; Liu Qi, non-independent director; Wang Jiayu, non-independent director; Yi Yang, independent director.Declared Dividend • May 05Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 12th May 2025 Payment date: 12th May 2025 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (44% earnings payout ratio) and cash flows (56% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 78% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Apr 24Chengdu Guibao Science & Technology Co.,Ltd. Approves Cash Dividend for 2024Chengdu Guibao Science & Technology Co.,Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 3.00000000 per 10 shares (tax included) for 2024.Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥17.82, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.42 per share.お知らせ • Apr 01Chengdu Guibao Science & Technology Co.,Ltd. Announces Profit Distribution Proposal for the Year 2024Chengdu Guibao Science & Technology Co.,Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 3.000000 for the year 2024.お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025Reported Earnings • Mar 30Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: CN¥0.61 (down from CN¥0.81 in FY 2023). Revenue: CN¥3.16b (up 21% from FY 2023). Net income: CN¥237.5m (down 25% from FY 2023). Profit margin: 7.5% (down from 12% in FY 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) also missed analyst estimates by 6.7%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.お知らせ • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: 6F, No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan ChinaNew Risk • Mar 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 7x cash flows per share). Share price has been volatile over the past 3 months (8.0% average weekly change).分析記事 • Feb 20Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Stock Rockets 27% But Many Are Still Ignoring The CompanyChengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) shares have had a really impressive month, gaining 27...Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥18.32, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 9.5% over the past three years.New Risk • Feb 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 7x cash flows per share). Share price has been volatile over the past 3 months (8.8% average weekly change).お知らせ • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 29, 2025分析記事 • Dec 17What Does Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Share Price Indicate?Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ), might not be a large cap stock, but it led the SZSE...New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 7x cash flows per share). Share price has been volatile over the past 3 months (11% average weekly change).分析記事 • Nov 19Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Stock Rockets 35% As Investors Are Less Pessimistic Than ExpectedChengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) shares have continued their recent momentum with a 35...Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥19.67, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years.分析記事 • Nov 08Chengdu Guibao Science & TechnologyLtd (SZSE:300019) May Have Issues Allocating Its CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Major Estimate Revision • Oct 30Consensus EPS estimates fall by 27%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥3.18b to CN¥3.23b. EPS estimate fell from CN¥0.896 to CN¥0.65 per share. Net income forecast to grow 48% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target of CN¥18.20 unchanged from last update. Share price fell 2.3% to CN¥14.31 over the past week.Reported Earnings • Oct 22Third quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.23 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.14 (down from CN¥0.23 in 3Q 2023). Revenue: CN¥974.1m (up 36% from 3Q 2023). Net income: CN¥56.7m (down 38% from 3Q 2023). Profit margin: 5.8% (down from 13% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 30%After last week's 30% share price gain to CN¥14.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.73 per share.分析記事 • Sep 30Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Subdued P/E Might Signal An OpportunityWhen close to half the companies in China have price-to-earnings ratios (or "P/E's") above 30x, you may consider...Major Estimate Revision • Sep 04Consensus EPS estimates increase by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥2.96b to CN¥3.21b. EPS estimate increased from CN¥0.83 to CN¥0.915 per share. Net income forecast to grow 43% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target of CN¥18.20 unchanged from last update. Share price rose 3.4% to CN¥11.00 over the past week.Reported Earnings • Aug 24Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.20 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.16 (down from CN¥0.20 in 2Q 2023). Revenue: CN¥684.0m (up 3.2% from 2Q 2023). Net income: CN¥61.6m (down 20% from 2Q 2023). Profit margin: 9.0% (down from 12% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.分析記事 • Aug 23Is It Too Late To Consider Buying Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019)?Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ), is not the largest company out there, but it saw...お知らせ • Jun 29Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024分析記事 • Jun 16Downgrade: Here's How Analysts See Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Performing In The Near TermOne thing we could say about the analysts on Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) - they aren't...Major Estimate Revision • Jun 15Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.35b to CN¥2.83b. EPS estimate fell from CN¥0.978 to CN¥0.72 per share. Net income forecast to grow 8.7% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target of CN¥18.20 unchanged from last update. Share price was steady at CN¥13.67 over the past week.Declared Dividend • Apr 29Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2024 Payment date: 30th April 2024 Dividend yield will be 2.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (39% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 106% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Buy Or Sell Opportunity • Apr 22Now 31% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to CN¥13.06. The fair value is estimated to be CN¥18.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has grown by 6.5%. Revenue is forecast to grow by 81% in 2 years. Earnings are forecast to grow by 76% in the next 2 years.Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥14.08, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 8.2% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥15.21 per share.Price Target Changed • Apr 11Price target decreased by 13% to CN¥18.20Down from CN¥20.94, the current price target is an average from 2 analysts. New target price is 14% above last closing price of CN¥16.01. Stock is down 6.9% over the past year. The company is forecast to post earnings per share of CN¥0.98 for next year compared to CN¥0.81 last year.分析記事 • Apr 09Investors Still Aren't Entirely Convinced By Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Earnings Despite 26% Price JumpChengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) shares have had a really impressive month, gaining 26...お知らせ • Mar 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024Reported Earnings • Mar 30Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 3.4%. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.お知らせ • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Chengdu, Sichuan China分析記事 • Mar 28Is Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Trading At A 29% Discount?Key Insights Chengdu Guibao Science & TechnologyLtd's estimated fair value is CN¥19.19 based on 2 Stage Free Cash Flow...分析記事 • Mar 12Should You Investigate Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) At CN¥14.50?Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ), is not the largest company out there, but it saw a...お知らせ • Feb 22Chengdu Guibao Science & Technology to Buy Hot Melt Adhesive FirmChengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) said it plans to buy hot melt adhesive firm with estimated valuation of CNY 480 million ($66.72 million).Reported Earnings • Feb 03Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)Full year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.47, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.41 per share.お知らせ • Dec 29Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024Reported Earnings • Oct 20Third quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.23 (up from CN¥0.16 in 3Q 2022). Revenue: CN¥718.8m (up 13% from 3Q 2022). Net income: CN¥91.2m (up 45% from 3Q 2022). Profit margin: 13% (up from 9.9% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 19, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2023 results on Oct 19, 2023Reported Earnings • Aug 12Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.15 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.15 in 2Q 2022). Revenue: CN¥662.9m (down 6.9% from 2Q 2022). Net income: CN¥77.3m (up 28% from 2Q 2022). Profit margin: 12% (up from 8.4% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 4% per year.お知らせ • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 12, 2023Reported Earnings • Mar 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.64 (down from CN¥0.70 in FY 2021). Revenue: CN¥2.69b (up 5.4% from FY 2021). Net income: CN¥250.3m (down 6.5% from FY 2021). Profit margin: 9.3% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 20% per year.Reported Earnings • Feb 12Full year 2022 earnings released: EPS: CN¥0.64 (vs CN¥0.70 in FY 2021)Full year 2022 results: EPS: CN¥0.64 (down from CN¥0.70 in FY 2021). Revenue: CN¥2.69b (up 5.4% from FY 2021). Net income: CN¥250.2m (down 6.5% from FY 2021). Profit margin: 9.3% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 19% per year.Board Change • Nov 16High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. Independent Director Xianye Tang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.16 (down from CN¥0.17 in 3Q 2021). Revenue: CN¥637.6m (down 5.4% from 3Q 2021). Net income: CN¥63.0m (down 7.7% from 3Q 2021). Profit margin: 9.9% (in line with 3Q 2021). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 18% per year.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.17, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 160% over the past three years.Price Target Changed • Aug 23Price target increased to CN¥25.83Up from CN¥19.94, the current price target is an average from 3 analysts. New target price is 33% above last closing price of CN¥19.41. Stock is down 23% over the past year. The company is forecast to post earnings per share of CN¥0.92 for next year compared to CN¥0.70 last year.Reported Earnings • Aug 21Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.17 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.17 in 2Q 2021). Revenue: CN¥711.9m (up 9.6% from 2Q 2021). Net income: CN¥60.1m (down 7.6% from 2Q 2021). Profit margin: 8.4% (down from 10.0% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 32%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.92, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 216% over the past three years.お知らせ • May 02Chengdu Guibao Science & Technology Co.,Ltd. Announces Board AppointmentsChengdu Guibao Science & Technology Co.,Ltd. approved the election of Wu Mengying, Liu Zhumeng, Guo Bin and Yang Limei as non-independent directors,the company also announced the election of Wang jin, Wang Yimin and Tang Xianye as independent Directors, at the EGM held on April 28, 2022.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 6 highly experienced directors. 3 independent directors (9 non-independent directors). Director Rundong Yue was the last director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Apr 23Chengdu Guibao Science & Technology Co.,Ltd. Proposes Cash Dividend on A Shares for the Year 2021, Payable on April 28, 2022Chengdu Guibao Science & Technology Co.,Ltd. proposed cash dividend per ten shares (tax included) on A shares of CNY 3.00000000 for the year 2021, payable on April 28, 2022. Record date to be April 27, 2022. Ex-date to be April 28, 2022.お知らせ • Apr 20Chengdu Guibao Science & Technology Co.,Ltd. Approves 2021 Profit Distribution PlanChengdu Guibao Science & Technology Co.,Ltd. approved cash dividend/10 shares (tax included): CNY 3.00000000 for the year 2021 at its Annual General Meeting held on 15 April 2022.Reported Earnings • Apr 17First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2022 results: EPS: CN¥0.11 (up from CN¥0.081 in 1Q 2021). Revenue: CN¥669.6m (up 87% from 1Q 2021). Net income: CN¥42.7m (up 51% from 1Q 2021). Profit margin: 6.4% (down from 7.9% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.6%. Earnings per share (EPS) missed analyst estimates by 4.4%. Over the next year, revenue is forecast to grow 23%, compared to a 50% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 26% per year.お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 15, 2022Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 15, 2022, at 14:00 China Standard Time. Agenda: To approve 2021 work report of the board of directors; to consider the 2021 work report of the supervisory committee; to consider the 2021 annual report and its summary; 2021 annual accounts; to consider the 2021 audited financial report; to consider the 2021 profit distribution plan; to consider the application for comprehensive credit line to banks by the Company and its wholly-owned subsidiaries; to consider the provision of guarantee for the bank comprehensive credit line applied for by wholly-owned subsidiaries; Cash management with idle funds; 2022 appointment of financial audit firm; to consider the repurchase and cancellation of some restricted stocks; and to consider the amendments to the Company's articles of association and authorization to the board to handle the industrial and commercial registration amendment.お知らせ • Mar 29Chengdu Guibao Science & Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021Chengdu Guibao Science & Technology Co.,Ltd. proposed final cash dividend/10 shares (tax included): CNY 3.00000000 for the year 2021.Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥17.10, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 135% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.09 per share.Buying Opportunity • Mar 04Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 12%. The fair value is estimated to be CN¥26.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% per annum over the last 3 years. Earnings per share has grown by 42% per annum over the last 3 years.Buying Opportunity • Feb 10Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥25.71, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% per annum over the last 3 years. Earnings per share has grown by 42% per annum over the last 3 years.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.19 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥673.9m (up 69% from 3Q 2020). Net income: CN¥68.3m (up 8.8% from 3Q 2020). Profit margin: 10% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥17.76, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 188% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥25.79 per share.Valuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to CN¥23.53, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 311% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.63 per share.Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥25.08, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 314% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.65 per share.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.19 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥649.5m (up 67% from 2Q 2020). Net income: CN¥65.1m (up 6.0% from 2Q 2020). Profit margin: 10.0% (down from 16% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 48% per year whereas the company’s share price has increased by 51% per year.Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥21.85, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 239% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥25.80 per share.Reported Earnings • Apr 21First quarter 2021 earnings released: EPS CN¥0.081 (vs CN¥0.031 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥358.7m (up 130% from 1Q 2020). Net income: CN¥28.3m (up 172% from 1Q 2020). Profit margin: 7.9% (up from 6.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 28Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.40 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥1.52b (up 50% from FY 2019). Net income: CN¥201.0m (up 53% from FY 2019). Profit margin: 13% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 24Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2020 results on Mar 27, 2021Is New 90 Day High Low • Feb 05New 90-day low: CN¥15.19The company is down 2.0% from its price of CN¥15.53 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.52, the stock is trading at a trailing P/E ratio of 33.5x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 85%.Valuation Update With 7 Day Price Move • Dec 16Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.44, the stock is trading at a trailing P/E ratio of 33.3x, down from the previous P/E ratio of 39.7x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past three years are 101%.Valuation Update With 7 Day Price Move • Nov 20Market bids up stock over the past weekAfter last week's 17% share price gain to CN¥23.65, the stock is trading at a trailing P/E ratio of 42.8x, up from the previous P/E ratio of 36.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 178%.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 30% share price gain to CN¥19.98, the stock is trading at a trailing P/E ratio of 36.1x, up from the previous P/E ratio of 27.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 107%.Is New 90 Day High Low • Nov 12New 90-day high: CN¥19.98The company is up 37% from its price of CN¥14.61 on 14 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period.Reported Earnings • Oct 23Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥183.0m, up 44% from the prior year. Total revenue was CN¥1.29b over the last 12 months, up 34% from the prior year.株主還元300019CN ChemicalsCN 市場7D1.4%-1.0%0.2%1Y-29.1%27.2%9.7%株主還元を見る業界別リターン: 300019過去 1 年間で27.2 % の収益を上げたCN Chemicals業界を下回りました。リターン対市場: 300019は、過去 1 年間で9.7 % のリターンを上げたCN市場を下回りました。価格変動Is 300019's price volatile compared to industry and market?300019 volatility300019 Average Weekly Movement8.4%Chemicals Industry Average Movement7.8%Market Average Movement7.3%10% most volatile stocks in CN Market12.5%10% least volatile stocks in CN Market4.4%安定した株価: 300019 、 CN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 300019の 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19981,887You Qiang Wangwww.guibao.cn成都桂宝科技有限公司は中華人民共和国でシリコーンシーラント及びその他の新素材の研究開発、製造、販売を行っている。カーテンウォール、複層ガラス、窓・ドア、室内装飾製品、工業用煙突防錆、下水プール防錆、電力設備防錆製品、太陽電池モジュール、電子熱伝導性ポッティング接着剤、土木製品；自動車用ヘッドライト、ハイトマン、エンジンシール、自動車内装製品、プレハブ建築製品、コンクリート建築目地用シリコン、電子機器用シーリング材、ポッティング接着剤、耐熱シリコン、シリコン接着剤、ポッティングコンパウンド、熱伝導性グリース、熱伝導性充填材、スピードレール軌道用コーキングシール。同社の製品は、建築カーテンウォール、中空ガラス、省エネドア・窓、プレハブ建築、太陽光発電、自動車製造、リチウム電池、電子機器、電力腐食保護、超高電圧送変電、鉄道輸送、民間航空などの分野で使用されている。成都貴寶科技有限公司は1998年に設立され、中華人民共和国の成都に本社を置いている。もっと見るChengdu Guibao Science & Technology Co.,Ltd. 基礎のまとめChengdu Guibao Science & TechnologyLtd の収益と売上を時価総額と比較するとどうか。300019 基礎統計学時価総額CN¥5.96b収益（TTM）CN¥253.60m売上高(TTM)CN¥3.82b23.5xPER（株価収益率1.6xP/Sレシオ300019 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計300019 損益計算書（TTM）収益CN¥3.82b売上原価CN¥3.05b売上総利益CN¥769.43mその他の費用CN¥515.82m収益CN¥253.60m直近の収益報告Mar 31, 2026次回決算日Aug 22, 2026一株当たり利益（EPS）0.65グロス・マージン20.16%純利益率6.65%有利子負債／自己資本比率5.4%300019 の長期的なパフォーマンスは？過去の実績と比較を見る配当金2.0%現在の配当利回り47%配当性向View Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/16 21:43終値2026/08/14 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Chengdu Guibao Science & Technology Co.,Ltd. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Wei MaoEverbright Securities Co. Ltd.Lin YangGuosen Securities Co., Ltd.Sen ZhaoHuatai Research
Buy Or Sell Opportunity • Jul 21Now 24% overvaluedOver the last 90 days, the stock has fallen 25% to CN¥14.09. The fair value is estimated to be CN¥11.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 42% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥16.12, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 19x in the Chemicals industry in China. Negligible returns to shareholders over past three years.
お知らせ • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026
Declared Dividend • Apr 27Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2026 Payment date: 30th April 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (47% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 50% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 21, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 21, 2026
Reported Earnings • Mar 30Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.71 (up from CN¥0.61 in FY 2024). Revenue: CN¥3.75b (up 19% from FY 2024). Net income: CN¥278.5m (up 17% from FY 2024). Profit margin: 7.4% (down from 7.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.
Buy Or Sell Opportunity • Jul 21Now 24% overvaluedOver the last 90 days, the stock has fallen 25% to CN¥14.09. The fair value is estimated to be CN¥11.39, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 47% in 2 years. Earnings are forecast to grow by 42% in the next 2 years.
Valuation Update With 7 Day Price Move • Jul 14Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to CN¥16.12, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 19x in the Chemicals industry in China. Negligible returns to shareholders over past three years.
お知らせ • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 22, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 22, 2026
Declared Dividend • Apr 27Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2026 Payment date: 30th April 2026 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (47% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 50% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 21, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 21, 2026
Reported Earnings • Mar 30Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: CN¥0.71 (up from CN¥0.61 in FY 2024). Revenue: CN¥3.75b (up 19% from FY 2024). Net income: CN¥278.5m (up 17% from FY 2024). Profit margin: 7.4% (down from 7.5% in FY 2024). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.
お知らせ • Mar 28Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 20, 2026, at 14:00 China Standard Time. Location: No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan China
Valuation Update With 7 Day Price Move • Mar 23Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥18.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 17% over the past three years.
Reported Earnings • Feb 10Full year 2025 earnings released: EPS: CN¥0.71 (vs CN¥0.61 in FY 2024)Full year 2025 results: EPS: CN¥0.71 (up from CN¥0.61 in FY 2024). Revenue: CN¥3.75b (up 19% from FY 2024). Net income: CN¥281.1m (up 18% from FY 2024). Profit margin: 7.5% (in line with FY 2024). Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has increased by 4% per year.
お知らせ • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 28, 2026Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 28, 2026
Valuation Update With 7 Day Price Move • Nov 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥21.09, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 24x in the Chemicals industry in China. Total returns to shareholders of 28% over the past three years.
Reported Earnings • Oct 22Third quarter 2025 earnings released: EPS: CN¥0.19 (vs CN¥0.14 in 3Q 2024)Third quarter 2025 results: EPS: CN¥0.19 (up from CN¥0.14 in 3Q 2024). Revenue: CN¥943.8m (down 3.1% from 3Q 2024). Net income: CN¥74.9m (up 32% from 3Q 2024). Profit margin: 7.9% (up from 5.8% in 3Q 2024). The increase in margin was driven by lower expenses. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 10% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Aug 26Second quarter 2025 earnings released: EPS: CN¥0.21 (vs CN¥0.16 in 2Q 2024)Second quarter 2025 results: EPS: CN¥0.21 (up from CN¥0.16 in 2Q 2024). Revenue: CN¥928.7m (up 36% from 2Q 2024). Net income: CN¥83.2m (up 35% from 2Q 2024). Profit margin: 9.0% (in line with 2Q 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 6% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Jul 10Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥24.32, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 18% over the past three years.
New Risk • Jul 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.9% average weekly change). Profit margins are more than 30% lower than last year (7.7% net profit margin).
お知らせ • Jul 02Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 23, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 23, 2025
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improves as stock rises 19%After last week's 19% share price gain to CN¥20.10, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 21x in the Chemicals industry in China. Total loss to shareholders of 5.1% over the past three years.
お知らせ • May 09Chengdu Guibao Science & Technology Co.,Ltd. Announces Director AppointmentsChengdu Guibao Science & Technology Co.,Ltd. at its EGM held on May 7, 2025, approved: Election and nomination of non-independent and independent directors: Zhao Kexing, non-independent director; Liu Qi, non-independent director; Wang Jiayu, non-independent director; Yi Yang, independent director.
Declared Dividend • May 05Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 12th May 2025 Payment date: 12th May 2025 Dividend yield will be 1.6%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (44% earnings payout ratio) and cash flows (56% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 78% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Apr 24Chengdu Guibao Science & Technology Co.,Ltd. Approves Cash Dividend for 2024Chengdu Guibao Science & Technology Co.,Ltd. at its Annual General Meeting held on 21 April 2025 approved cash dividend of CNY 3.00000000 per 10 shares (tax included) for 2024.
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥17.82, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥17.42 per share.
お知らせ • Apr 01Chengdu Guibao Science & Technology Co.,Ltd. Announces Profit Distribution Proposal for the Year 2024Chengdu Guibao Science & Technology Co.,Ltd. announced profit distribution proposal final Cash dividend/10 shares (tax included) is CNY 3.000000 for the year 2024.
お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025
Reported Earnings • Mar 30Full year 2024 earnings: EPS and revenues miss analyst expectationsFull year 2024 results: EPS: CN¥0.61 (down from CN¥0.81 in FY 2023). Revenue: CN¥3.16b (up 21% from FY 2023). Net income: CN¥237.5m (down 25% from FY 2023). Profit margin: 7.5% (down from 12% in FY 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.3%. Earnings per share (EPS) also missed analyst estimates by 6.7%. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year.
お知らせ • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 21, 2025, at 14:00 China Standard Time. Location: 6F, No. 16, Xinyuan Avenue, Hi-tech Zone, Chengdu, Sichuan China
New Risk • Mar 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 7x cash flows per share). Share price has been volatile over the past 3 months (8.0% average weekly change).
分析記事 • Feb 20Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Stock Rockets 27% But Many Are Still Ignoring The CompanyChengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) shares have had a really impressive month, gaining 27...
Valuation Update With 7 Day Price Move • Feb 20Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥18.32, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 19x in the Chemicals industry in China. Total loss to shareholders of 9.5% over the past three years.
New Risk • Feb 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 7x cash flows per share). Share price has been volatile over the past 3 months (8.8% average weekly change).
お知らせ • Dec 31Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 29, 2025Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 29, 2025
分析記事 • Dec 17What Does Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Share Price Indicate?Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ), might not be a large cap stock, but it led the SZSE...
New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (dividend per share is over 7x cash flows per share). Share price has been volatile over the past 3 months (11% average weekly change).
分析記事 • Nov 19Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Stock Rockets 35% As Investors Are Less Pessimistic Than ExpectedChengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) shares have continued their recent momentum with a 35...
Valuation Update With 7 Day Price Move • Nov 19Investor sentiment improves as stock rises 27%After last week's 27% share price gain to CN¥19.67, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 14% over the past three years.
分析記事 • Nov 08Chengdu Guibao Science & TechnologyLtd (SZSE:300019) May Have Issues Allocating Its CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Major Estimate Revision • Oct 30Consensus EPS estimates fall by 27%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from CN¥3.18b to CN¥3.23b. EPS estimate fell from CN¥0.896 to CN¥0.65 per share. Net income forecast to grow 48% next year vs 51% growth forecast for Chemicals industry in China. Consensus price target of CN¥18.20 unchanged from last update. Share price fell 2.3% to CN¥14.31 over the past week.
Reported Earnings • Oct 22Third quarter 2024 earnings released: EPS: CN¥0.14 (vs CN¥0.23 in 3Q 2023)Third quarter 2024 results: EPS: CN¥0.14 (down from CN¥0.23 in 3Q 2023). Revenue: CN¥974.1m (up 36% from 3Q 2023). Net income: CN¥56.7m (down 38% from 3Q 2023). Profit margin: 5.8% (down from 13% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024
Valuation Update With 7 Day Price Move • Sep 30Investor sentiment improves as stock rises 30%After last week's 30% share price gain to CN¥14.18, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.73 per share.
分析記事 • Sep 30Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Subdued P/E Might Signal An OpportunityWhen close to half the companies in China have price-to-earnings ratios (or "P/E's") above 30x, you may consider...
Major Estimate Revision • Sep 04Consensus EPS estimates increase by 10%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥2.96b to CN¥3.21b. EPS estimate increased from CN¥0.83 to CN¥0.915 per share. Net income forecast to grow 43% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target of CN¥18.20 unchanged from last update. Share price rose 3.4% to CN¥11.00 over the past week.
Reported Earnings • Aug 24Second quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.20 in 2Q 2023)Second quarter 2024 results: EPS: CN¥0.16 (down from CN¥0.20 in 2Q 2023). Revenue: CN¥684.0m (up 3.2% from 2Q 2023). Net income: CN¥61.6m (down 20% from 2Q 2023). Profit margin: 9.0% (down from 12% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 30% per year, which means it is significantly lagging earnings.
分析記事 • Aug 23Is It Too Late To Consider Buying Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019)?Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ), is not the largest company out there, but it saw...
お知らせ • Jun 29Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024
分析記事 • Jun 16Downgrade: Here's How Analysts See Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Performing In The Near TermOne thing we could say about the analysts on Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) - they aren't...
Major Estimate Revision • Jun 15Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥3.35b to CN¥2.83b. EPS estimate fell from CN¥0.978 to CN¥0.72 per share. Net income forecast to grow 8.7% next year vs 50% growth forecast for Chemicals industry in China. Consensus price target of CN¥18.20 unchanged from last update. Share price was steady at CN¥13.67 over the past week.
Declared Dividend • Apr 29Dividend of CN¥0.30 announcedDividend of CN¥0.30 is the same as last year. Ex-date: 30th April 2024 Payment date: 30th April 2024 Dividend yield will be 2.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (39% earnings payout ratio) and cash flows (67% cash payout ratio). The dividend has increased by an average of 12% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 106% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Buy Or Sell Opportunity • Apr 22Now 31% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.7% to CN¥13.06. The fair value is estimated to be CN¥18.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.2% over the last 3 years. Earnings per share has grown by 6.5%. Revenue is forecast to grow by 81% in 2 years. Earnings are forecast to grow by 76% in the next 2 years.
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to CN¥14.08, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 15x in the Chemicals industry in China. Total loss to shareholders of 8.2% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥15.21 per share.
Price Target Changed • Apr 11Price target decreased by 13% to CN¥18.20Down from CN¥20.94, the current price target is an average from 2 analysts. New target price is 14% above last closing price of CN¥16.01. Stock is down 6.9% over the past year. The company is forecast to post earnings per share of CN¥0.98 for next year compared to CN¥0.81 last year.
分析記事 • Apr 09Investors Still Aren't Entirely Convinced By Chengdu Guibao Science & Technology Co.,Ltd.'s (SZSE:300019) Earnings Despite 26% Price JumpChengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ) shares have had a really impressive month, gaining 26...
お知らせ • Mar 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 20, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 20, 2024
Reported Earnings • Mar 30Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 15%. Earnings per share (EPS) also missed analyst estimates by 3.4%. Revenue is forecast to grow 24% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
お知らせ • Mar 29Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 19, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Chengdu, Sichuan China
分析記事 • Mar 28Is Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) Trading At A 29% Discount?Key Insights Chengdu Guibao Science & TechnologyLtd's estimated fair value is CN¥19.19 based on 2 Stage Free Cash Flow...
分析記事 • Mar 12Should You Investigate Chengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) At CN¥14.50?Chengdu Guibao Science & Technology Co.,Ltd. ( SZSE:300019 ), is not the largest company out there, but it saw a...
お知らせ • Feb 22Chengdu Guibao Science & Technology to Buy Hot Melt Adhesive FirmChengdu Guibao Science & Technology Co.,Ltd. (SZSE:300019) said it plans to buy hot melt adhesive firm with estimated valuation of CNY 480 million ($66.72 million).
Reported Earnings • Feb 03Full year 2023 earnings released: EPS: CN¥0.81 (vs CN¥0.64 in FY 2022)Full year 2023 results: EPS: CN¥0.81 (up from CN¥0.64 in FY 2022). Revenue: CN¥2.61b (down 3.3% from FY 2022). Net income: CN¥315.2m (up 26% from FY 2022). Profit margin: 12% (up from 9.3% in FY 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to CN¥12.47, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥5.41 per share.
お知らせ • Dec 29Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 29, 2024
Reported Earnings • Oct 20Third quarter 2023 earnings released: EPS: CN¥0.23 (vs CN¥0.16 in 3Q 2022)Third quarter 2023 results: EPS: CN¥0.23 (up from CN¥0.16 in 3Q 2022). Revenue: CN¥718.8m (up 13% from 3Q 2022). Net income: CN¥91.2m (up 45% from 3Q 2022). Profit margin: 13% (up from 9.9% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • Sep 30Chengdu Guibao Science & Technology Co.,Ltd. to Report Q3, 2023 Results on Oct 19, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report Q3, 2023 results on Oct 19, 2023
Reported Earnings • Aug 12Second quarter 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.15 in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.15 in 2Q 2022). Revenue: CN¥662.9m (down 6.9% from 2Q 2022). Net income: CN¥77.3m (up 28% from 2Q 2022). Profit margin: 12% (up from 8.4% in 2Q 2022). The increase in margin was driven by lower expenses. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 4% per year.
お知らせ • Jul 01Chengdu Guibao Science & Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 12, 2023Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 12, 2023
Reported Earnings • Mar 26Full year 2022 earnings: EPS and revenues miss analyst expectationsFull year 2022 results: EPS: CN¥0.64 (down from CN¥0.70 in FY 2021). Revenue: CN¥2.69b (up 5.4% from FY 2021). Net income: CN¥250.3m (down 6.5% from FY 2021). Profit margin: 9.3% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 5.8%. Earnings per share (EPS) also missed analyst estimates by 11%. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 20% per year.
Reported Earnings • Feb 12Full year 2022 earnings released: EPS: CN¥0.64 (vs CN¥0.70 in FY 2021)Full year 2022 results: EPS: CN¥0.64 (down from CN¥0.70 in FY 2021). Revenue: CN¥2.69b (up 5.4% from FY 2021). Net income: CN¥250.2m (down 6.5% from FY 2021). Profit margin: 9.3% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 27% p.a. on average during the next 2 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year whereas the company’s share price has increased by 19% per year.
Board Change • Nov 16High number of new and inexperienced directorsThere are 9 new directors who have joined the board in the last 3 years. The company's board is composed of: 9 new directors. 3 experienced directors. No highly experienced directors. Independent Director Xianye Tang is the most experienced director on the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 25Third quarter 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.17 in 3Q 2021)Third quarter 2022 results: EPS: CN¥0.16 (down from CN¥0.17 in 3Q 2021). Revenue: CN¥637.6m (down 5.4% from 3Q 2021). Net income: CN¥63.0m (down 7.7% from 3Q 2021). Profit margin: 9.9% (in line with 3Q 2021). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 18% per year.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.17, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 160% over the past three years.
Price Target Changed • Aug 23Price target increased to CN¥25.83Up from CN¥19.94, the current price target is an average from 3 analysts. New target price is 33% above last closing price of CN¥19.41. Stock is down 23% over the past year. The company is forecast to post earnings per share of CN¥0.92 for next year compared to CN¥0.70 last year.
Reported Earnings • Aug 21Second quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.17 in 2Q 2021)Second quarter 2022 results: EPS: CN¥0.15 (down from CN¥0.17 in 2Q 2021). Revenue: CN¥711.9m (up 9.6% from 2Q 2021). Net income: CN¥60.1m (down 7.6% from 2Q 2021). Profit margin: 8.4% (down from 10.0% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 32%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 42% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.92, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 216% over the past three years.
お知らせ • May 02Chengdu Guibao Science & Technology Co.,Ltd. Announces Board AppointmentsChengdu Guibao Science & Technology Co.,Ltd. approved the election of Wu Mengying, Liu Zhumeng, Guo Bin and Yang Limei as non-independent directors,the company also announced the election of Wang jin, Wang Yimin and Tang Xianye as independent Directors, at the EGM held on April 28, 2022.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 6 highly experienced directors. 3 independent directors (9 non-independent directors). Director Rundong Yue was the last director to join the board, commencing their role in 2011. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Apr 23Chengdu Guibao Science & Technology Co.,Ltd. Proposes Cash Dividend on A Shares for the Year 2021, Payable on April 28, 2022Chengdu Guibao Science & Technology Co.,Ltd. proposed cash dividend per ten shares (tax included) on A shares of CNY 3.00000000 for the year 2021, payable on April 28, 2022. Record date to be April 27, 2022. Ex-date to be April 28, 2022.
お知らせ • Apr 20Chengdu Guibao Science & Technology Co.,Ltd. Approves 2021 Profit Distribution PlanChengdu Guibao Science & Technology Co.,Ltd. approved cash dividend/10 shares (tax included): CNY 3.00000000 for the year 2021 at its Annual General Meeting held on 15 April 2022.
Reported Earnings • Apr 17First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFirst quarter 2022 results: EPS: CN¥0.11 (up from CN¥0.081 in 1Q 2021). Revenue: CN¥669.6m (up 87% from 1Q 2021). Net income: CN¥42.7m (up 51% from 1Q 2021). Profit margin: 6.4% (down from 7.9% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.6%. Earnings per share (EPS) missed analyst estimates by 4.4%. Over the next year, revenue is forecast to grow 23%, compared to a 50% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 31% per year whereas the company’s share price has increased by 26% per year.
お知らせ • Mar 31Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 15, 2022Chengdu Guibao Science & Technology Co.,Ltd., Annual General Meeting, Apr 15, 2022, at 14:00 China Standard Time. Agenda: To approve 2021 work report of the board of directors; to consider the 2021 work report of the supervisory committee; to consider the 2021 annual report and its summary; 2021 annual accounts; to consider the 2021 audited financial report; to consider the 2021 profit distribution plan; to consider the application for comprehensive credit line to banks by the Company and its wholly-owned subsidiaries; to consider the provision of guarantee for the bank comprehensive credit line applied for by wholly-owned subsidiaries; Cash management with idle funds; 2022 appointment of financial audit firm; to consider the repurchase and cancellation of some restricted stocks; and to consider the amendments to the Company's articles of association and authorization to the board to handle the industrial and commercial registration amendment.
お知らせ • Mar 29Chengdu Guibao Science & Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021Chengdu Guibao Science & Technology Co.,Ltd. proposed final cash dividend/10 shares (tax included): CNY 3.00000000 for the year 2021.
Valuation Update With 7 Day Price Move • Mar 15Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to CN¥17.10, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 135% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.09 per share.
Buying Opportunity • Mar 04Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 12%. The fair value is estimated to be CN¥26.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% per annum over the last 3 years. Earnings per share has grown by 42% per annum over the last 3 years.
Buying Opportunity • Feb 10Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 14%. The fair value is estimated to be CN¥25.71, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 35% per annum over the last 3 years. Earnings per share has grown by 42% per annum over the last 3 years.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.19 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥673.9m (up 69% from 3Q 2020). Net income: CN¥68.3m (up 8.8% from 3Q 2020). Profit margin: 10% (down from 16% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has increased by 52% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to CN¥17.76, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 188% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥25.79 per share.
Valuation Update With 7 Day Price Move • Sep 08Investor sentiment deteriorated over the past weekAfter last week's 21% share price decline to CN¥23.53, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 311% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.63 per share.
Valuation Update With 7 Day Price Move • Aug 24Investor sentiment improved over the past weekAfter last week's 26% share price gain to CN¥25.08, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 314% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥23.65 per share.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.19 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥649.5m (up 67% from 2Q 2020). Net income: CN¥65.1m (up 6.0% from 2Q 2020). Profit margin: 10.0% (down from 16% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 48% per year whereas the company’s share price has increased by 51% per year.
Valuation Update With 7 Day Price Move • Aug 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥21.85, the stock trades at a forward P/E ratio of 29x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 239% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥25.80 per share.
Reported Earnings • Apr 21First quarter 2021 earnings released: EPS CN¥0.081 (vs CN¥0.031 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥358.7m (up 130% from 1Q 2020). Net income: CN¥28.3m (up 172% from 1Q 2020). Profit margin: 7.9% (up from 6.7% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 28Full year 2020 earnings released: EPS CN¥0.61 (vs CN¥0.40 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: CN¥1.52b (up 50% from FY 2019). Net income: CN¥201.0m (up 53% from FY 2019). Profit margin: 13% (in line with FY 2019). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 24Chengdu Guibao Science & Technology Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021Chengdu Guibao Science & Technology Co.,Ltd. announced that they will report fiscal year 2020 results on Mar 27, 2021
Is New 90 Day High Low • Feb 05New 90-day low: CN¥15.19The company is down 2.0% from its price of CN¥15.53 on 06 November 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
Valuation Update With 7 Day Price Move • Jan 19Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥18.52, the stock is trading at a trailing P/E ratio of 33.5x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 85%.
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to CN¥18.44, the stock is trading at a trailing P/E ratio of 33.3x, down from the previous P/E ratio of 39.7x. This compares to an average P/E of 37x in the Chemicals industry in China. Total returns to shareholders over the past three years are 101%.
Valuation Update With 7 Day Price Move • Nov 20Market bids up stock over the past weekAfter last week's 17% share price gain to CN¥23.65, the stock is trading at a trailing P/E ratio of 42.8x, up from the previous P/E ratio of 36.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 178%.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 30% share price gain to CN¥19.98, the stock is trading at a trailing P/E ratio of 36.1x, up from the previous P/E ratio of 27.7x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 107%.
Is New 90 Day High Low • Nov 12New 90-day high: CN¥19.98The company is up 37% from its price of CN¥14.61 on 14 August 2020. The Chinese market is up 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period.
Reported Earnings • Oct 23Third quarter earnings releasedOver the last 12 months the company has reported total profits of CN¥183.0m, up 44% from the prior year. Total revenue was CN¥1.29b over the last 12 months, up 34% from the prior year.
